A detailed history of American International Group, Inc. transactions in Vaxxinity, Inc. stock. As of the latest transaction made, American International Group, Inc. holds 21,003 shares of VAXX stock, worth $5,670. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,003
Previous 21,185 0.86%
Holding current value
$5,670
Previous $18,000 16.67%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$0.62 - $0.86 $112 - $156
-182 Reduced 0.86%
21,003 $15,000
Q4 2023

Feb 13, 2024

SELL
$0.7 - $1.31 $59 - $111
-85 Reduced 0.4%
21,185 $18,000
Q3 2023

Nov 13, 2023

BUY
$1.25 - $3.0 $945 - $2,268
756 Added 3.69%
21,270 $29,000
Q2 2023

Aug 04, 2023

BUY
$1.73 - $2.79 $35,489 - $57,234
20,514 New
20,514 $51,000

Others Institutions Holding VAXX

About Vaxxinity, Inc.


  • Ticker VAXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 112,150,000
  • Market Cap $30.3M
  • Description
  • Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...
More about VAXX
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.